The Scientific Advisory Team at Zynerba Pharma provides expert guidance on the research and development of novel cannabinoid therapeutics, ensuring they meet the highest scientific and clinical standards. Comprised of leading scientific advisors and coordinated by the Research Study Coordinator, this team evaluates clinical data, advises on study designs, regulatory strategies, and helps align the company's initiatives with the latest scientific advancements to address unmet medical needs in neuropsychiatric disorders.
View all